Skip to main content
Premium Trial:

Request an Annual Quote

TcLand Teams with Radboud Univ. on Biomarkers for RA Drug Response

NEW YORK (GenomeWeb News) – TcLand Expression and Radboud University Nijmegen Medical Center today announced that they will collaborate on looking for biomarkers that predict the effectiveness of drugs for rheumatoid arthritis.

The partners aim to develop a companion diagnostic test for rheumatoid arthritis drugs.

Alessandra Cervino, VP of R&D and biostatistics for Nantes, France-based TcLand Expression, said in a statement that the firm has already developed a test to predict response to rheumatoid arthritis drug infliximab. Now, the firm will work with the researchers at RUNMC to analyze the whole class of anti-TNF drugs.

Further terms of the alliance were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.